+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

From
From
From
Pipeline of Mesothelin-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of Mesothelin-Targeted Immunotherapies

  • Report
  • December 2025
  • Global
From
Pipeline of c-Met-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of c-Met-Targeted Immunotherapies

  • Report
  • December 2025
  • Global
From
Pipeline of Her3-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of Her3-Targeted Immunotherapies

  • Report
  • December 2025
  • Global
From
Pipeline of CD73 Inhibitors - Product Thumbnail Image

Pipeline of CD73 Inhibitors

  • Report
  • December 2025
  • Global
From
Pipeline of EpCAM-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of EpCAM-Targeted Immunotherapies

  • Report
  • December 2025
  • Global
From
Pipeline of Nectin-4-Targeted Immunotherapies - Product Thumbnail Image

Pipeline of Nectin-4-Targeted Immunotherapies

  • Report
  • December 2025
  • Global
From
India Telemedicine for Rural Oncology Care Market - Product Thumbnail Image

India Telemedicine for Rural Oncology Care Market

  • Report
  • October 2025
  • 86 Pages
  • India
From
Bladder Cancer: Epidemiology Forecast to 2033 - Product Thumbnail Image

Bladder Cancer: Epidemiology Forecast to 2033

  • Report
  • October 2024
  • 70 Pages
  • Global
From
Oncologists in the US - Industry Market Research Report - Product Thumbnail Image

Oncologists in the US - Industry Market Research Report

  • Report
  • May 2024
  • 54 Pages
  • United States
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more